Viral regulatory sequences may be exploited as immunogens for prophylactic
and therapeutic vaccination. They are subjected to less interstrain variati
on than the envelope proteins, and are thus of interest for immunization ap
proaches. Deleted forms of regulatory nef, tat and rev genes have been asso
ciated with less virulent human infections. The construction of primary HIV
DNA plasmids and their capacity to produce functional and immunogenic prot
eins are demonstrated. HIV regulatory proteins carry several amino acid str
etches with good binding capacity to HLA class I molecules, and are therefo
re potential CTL epitopes. Also antibody responses are induced, which may s
erve to inhibit regulatory molecules that have intercellular trafficking.